US Patent Issued to INTRABIO on Oct. 7 for "Pharmaceutical compositions and uses directed to lysosomal storage disorders" (German Inventor)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,863, issued on Oct. 7, was assigned to INTRABIO Ltd. (London).

"Pharmaceutical compositions and uses directed to lysosomal storage disorders" was invented by Michael Strupp (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides for treating lysosomal storage disorders (LSDs) comprising administering acetyl-leucine or a pharmaceutically acceptable salt thereof."

The patent was filed on Feb. 2, 2024, under Application No. 18/430,858.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=...